1. Home
  2. REVG vs NRIX Comparison

REVG vs NRIX Comparison

Compare REVG & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVG
    SELLHOLDBUYas of 2 days ago
  • NRIX
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • REVG 2008
  • NRIX 2009
  • Country
  • REVG United States
  • NRIX United States
  • Employees
  • REVG N/A
  • NRIX N/A
  • Industry
  • REVG Auto Manufacturing
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • REVG Consumer Discretionary
  • NRIX Health Care
  • Exchange
  • REVG Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • REVG 1.3B
  • NRIX 1.3B
  • IPO Year
  • REVG 2017
  • NRIX 2020
  • Fundamental
  • Price
  • REVG $31.80
  • NRIX $19.83
  • Analyst Decision
  • REVG Hold
  • NRIX Strong Buy
  • Analyst Count
  • REVG 4
  • NRIX 17
  • Target Price
  • REVG $33.75
  • NRIX $30.29
  • AVG Volume (30 Days)
  • REVG 738.9K
  • NRIX 988.4K
  • Earning Date
  • REVG 12-11-2024
  • NRIX 02-13-2025
  • Dividend Yield
  • REVG 0.76%
  • NRIX N/A
  • EPS Growth
  • REVG 512.99
  • NRIX N/A
  • EPS
  • REVG 4.72
  • NRIX N/A
  • Revenue
  • REVG $2,380,200,000.00
  • NRIX $56,424,000.00
  • Revenue This Year
  • REVG $5.24
  • NRIX N/A
  • Revenue Next Year
  • REVG N/A
  • NRIX $5.92
  • P/E Ratio
  • REVG $6.73
  • NRIX N/A
  • Revenue Growth
  • REVG N/A
  • NRIX N/A
  • 52 Week Low
  • REVG $16.00
  • NRIX $7.65
  • 52 Week High
  • REVG $35.96
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • REVG 51.99
  • NRIX 38.42
  • Support Level
  • REVG $29.53
  • NRIX $19.38
  • Resistance Level
  • REVG $33.97
  • NRIX $21.67
  • Average True Range (ATR)
  • REVG 1.54
  • NRIX 1.34
  • MACD
  • REVG -0.10
  • NRIX 0.00
  • Stochastic Oscillator
  • REVG 35.30
  • NRIX 12.61

Stock Price Comparison Chart: REVG vs NRIX

REVG
NRIX
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0510152025303540455055REVG VS NRIX

About REVG REV Group Inc.

REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. It provides customized vehicle solutions for applications including essential needs, industrial and commercial, and consumer leisure. The operating segments of the company are Fire & Emergency, Commercial, and Recreation. The products of the company are sold to municipalities, government agencies, private contractors, consumers, and industrial and commercial end-users. It derives a majority of the revenue from the Fire and Emergency segment which includes manufacturing of fire apparatus and ambulance products. The company operates in the United States, Canada, and the rest of the world.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use